Pfizer’s stock drops after drug giant lowers its revenue forecast


The pharmaceutical company updated its sales guidance for 2025, saying it now expects $62 billion in revenue for the year.

You May Also Like

Stock buybacks are surging. Here’s why it matters to your portfolio.

This year’s record-setting pace of share buybacks is bearish.

Panera confidentially files for IPO in 2024: report

Casual-dining restaurant chain Panera Brands has confidentially filed for an initial public…

Why China’s ‘slow’ bull market could turn into a stampede, according to strategist

The steady but strong gains for Chinese stocks since it announced stimulus…

Naomi Watts reveals terrifying days alone in her home as L.A. fires close in

Watts says she ended up alone inside her $6 million Brentwood mansion…